a combination b and t cell approach to sars-cov-2 vaccination
Published 4 years ago • 654 plays • Length 49:12Download video MP4
Download video MP3
Similar videos
-
1:02:22
covid-19 t-cell data: mapping out sars- cov-2 antigen & t-cell repertoires
-
30:33
webinar: t-cell immunity and covid-19
-
59:46
indoor biotechnologies’ sars-cov-2 proteins and simple t cell test
-
16:02
indoor biotechnologies’ sars-cov-2 simple t cell test
-
1:58
sars-cov-2–specific t cell activation with sars-cov-2 peptivator® peptide pools
-
34:43
immunogenicity of aav vectors and transgenes - roland herzog
-
1:27:03
engineering optimized anti sars cov 2 antibody therapeutics
-
12:56
identifying the peptides that activate t cells in covid-19 patients - albert wong
-
31:54
b-cell lineage analysis and covid-19 (k. hoehn)
-
55:36
harnessing the power of t- cells using a programmable receptor
-
2:22
combining car-ts & bispecific antibodies
-
49:42
characterization and selection of antibodies for covid-19 diagnostics
-
41:22
first fda-authorized use of crispr diagnostics for covid-19…next up: stopcovid!
-
30:36
bispecific antibodies to engage vγ9vδ2-t cells for cancer immunotherapy
-
52:50
10. biomolecular engineering: engineering of immunity (cont.)
-
8:09
iedb & immunomebrowser: sars-cov-2 t cell data
-
33:43
synthetic immunology next-generation antibody engineering - synbiobeta 2019
-
49:27
antibody engineering & therapeutics digital week - acrobio's presentation
-
15:41
immunoglobulin and t cell receptor genetics